Drawing for ELORA.

USPTO serial 79395224

ELORA.

Reviewed by CopyMark Law Group

Reg. 7895116Status 700Registered
Filing date
Status date
Registration date
Aug 19, 2025
Examiner
BLAKESLEE, RICHARD A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ELORA.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas M. Joseph

Thomas M. Joseph OGC Law, LLC1575 McFarland Road, Suite 6Pittsburgh, PA 15216United States

Goods and services

ClassDescriptionStatusFirst use
010Tissue sampling devices for medical use, namely, medical specimen containers for breast tissue; medical apparatus and instruments for use in breast cancer diagnostic surgery and breast cancer tumor removal surgery procedures; medical probes; probes for medical purposes; medical testing apparatus, namely, intraoperative imaging technology devices for use in breast cancer surgery; medical diagnostic apparatus for diagnosing breast cancer; medical imaging apparatus; medical diagnostic testing apparatus for diagnosing breast cancer; test probes for medical use; testing probes for medical diagnostic purposes; testing probes for medical purposes; apparatus for medical use, namely, optical coherence tomography probes and micro-elastography probes for mapping and for identifying breast cancer; apparatus for medical analysis, namely, optical coherence tomography probes and micro-elastography probes for mapping and for identifying breast cancer; apparatus for medical diagnosis, namely, optical coherence tomography probes and micro-elastography probes for mapping and for identifying breast cancer; apparatus for medical diagnostic purposes, namely, optical coherence tomography probes and micro-elastography probes for mapping and for identifying breast cancer; medical apparatus for diagnostic purposes, namely, apparatus for performing optical coherence tomography and micro-elastography for mapping and for identifying breast cancer; diagnostic apparatus for medical purposes, namely, handheld combination optical coherence tomography and micro-elastography probe; diagnostic imaging apparatus for medical use, namely, an optical coherence tomography and micro-elastography apparatus for mapping and for identifying breast cancer; medical probes connected to micro-processing apparatus for medical diagnosis; apparatus for analyzing images for medical use, namely, an optical coherence tomography and micro-elastography imaging apparatus; apparatus for medical image formation, namely an optical coherence tomography and micro-elastography imaging deviceACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 19, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 28, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 28, 2026FIMPFINAL DISPOSITION PROCESSED—
Nov 19, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 11, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 11, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 11, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 11, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 11, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 11, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 11, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 11, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 24, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 8, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 8, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 4, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 19, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 19, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 1, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 1, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 25, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 29, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 28, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 28, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 28, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
May 5, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 5, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 5, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 3, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 2, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 2, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 30, 2025ATRVATTORNEY REVIEW COMPLETED—
Jan 24, 2025LIMELIMITATION FROM THE IB - REQUEST EXAM REVIEW—
Nov 23, 2024RFNTREFUSAL PROCESSED BY IB—
Nov 4, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 4, 2024RFRRREFUSAL PROCESSED BY MPU—
Oct 30, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 29, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2024DOCKASSIGNED TO EXAMINER—
Aug 10, 2024LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jun 15, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 14, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
May 14, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 9, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance